Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paragastric Block for Pain and PONV After Sleeve Gastrectomy
NCT07274215Recruiting
- Sponsor
- Umraniye Education and Research Hospital
- Start
- Oct 2025
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of bupivacaine in postoperative pain and postoperative nausea and vomiting (PONV) (2 arms), sponsored by Umraniye Education and Research Hospital. Primary endpoint: Visual Analog Scale for Visceral Pain at 2 hours. Started Oct 2025; status: recruiting.
02
Drugs
bupivacaine
03
Conditions
postoperative painpostoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT07274215.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07274215.